Fintel reports that on January 31, 2025, Goldman Sachs downgraded their outlook for Occidental Petroleum (LSE:0KAK) from Neutral to Sell. As of January 28, 2025, the average one-year price target ...

Goldman Sachs Asset Management (GSAM) is a world-renowned company that has been providing investment management, portfolio design and advisory services to individual and institutional investors ...

Fintel reports that on January 31, 2025, Goldman Sachs downgraded their outlook for Occidental Petroleum (WBAG:OXYP) from Neutral to Sell. There are 1,826 funds or institutions reporting positions ...

Fintel reports that on January 27, 2025, Goldman Sachs upgraded their outlook for Twilio (WBAG:TWLO) from Neutral to Buy. There are 1,067 funds or institutions reporting positions in Twilio.

Deep-pocketed investors have adopted a bearish approach towards Goldman Sachs Gr (NYSE:GS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

Fintel reports that on January 30, 2025, Goldman Sachs upgraded their outlook for RH (LSE:0KTF) from Sell to Neutral. There are 794 funds or institutions reporting positions in RH. This is an ...

Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (WBAG:MRNA) from Buy to Neutral. There are 1,449 funds or institutions reporting positions in Moderna.

Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (XTRA:0QF) from Buy to Neutral. As of January 28, 2025, the average one-year price target for Moderna is ...

Fintel reports that on January 30, 2025, Goldman Sachs upgraded their outlook for RH (NYSE:RH) from Sell to Neutral. As of January 29, 2025, the average one-year price target for RH is $467.74/share.